In prostate cancer, the presence of VEGF ligand expression is frequently increased and is regulated by various stimulants, including tumour necrosis factors (TNF) α- and β and interleukin-1 (IL-1) [32]. The gene discussed is VEGFA; the disease is prostate cancer.